Comparison of Standard (7–14 Days) versus Extended (>14 Days) Intravenous Antibiotic Treatment for Vesicoureteral Reflux-Associated Acute Pyelonephritis in Children: A Retrospective Cohort Study
This retrospective cohort study of 99 children with vesicoureteral reflux-associated acute pyelonephritis found that extending intravenous antibiotic treatment beyond 14 days provided no significant benefit over the standard 7–14 day regimen in reducing recurrence rates, total infection episodes, or adverse outcomes.